ZA847409B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number: ZA847409B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1983-09-23

Application number

ZA847409A

Other languages

English (en)

Inventor

Robert Charles Hider

George Kontoghiorghes

Jack Silver

Michael Arthur Stockham

Original Assignee

Nat Res Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-09-23

Filing date

1984-09-20

Publication date

1986-05-28

1984-09-20 Application filed by Nat Res Dev filed Critical Nat Res Dev

1986-05-28 Publication of ZA847409B publication Critical patent/ZA847409B/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)

ZA847409A 1983-09-23 1984-09-20 Pharmaceutical compositions ZA847409B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB838325496A GB8325496D0 (en)	1983-09-23	1983-09-23	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ZA847409B true ZA847409B (en)	1986-05-28

Family

ID=10549201

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA847409A ZA847409B (en)	1983-09-23	1984-09-20	Pharmaceutical compositions

Country Status (11)

Country	Link
US (1)	US4587240A (fr)
EP (1)	EP0138420B1 (fr)
JP (2)	JPS6094966A (fr)
CY (1)	CY1574A (fr)
DE (1)	DE3480599D1 (fr)
DK (1)	DK161703C (fr)
GB (2)	GB8325496D0 (fr)
GR (1)	GR80444B (fr)
HK (1)	HK7091A (fr)
SG (1)	SG93290G (fr)
ZA (1)	ZA847409B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8308055D0 (en) *	1983-03-24	1983-05-05	Hider R C	Pharmaceutical compositions
GB8308054D0 (en) *	1983-03-24	1983-05-05	Hider R C	Pharmaceutical compositions
US4912118A (en) *	1983-09-23	1990-03-27	National Research Development Corporation	Pharmaceutical compositions
USRE34313E (en) *	1983-09-23	1993-07-13	National Research Development Corporation	Pharmaceutical compositions
GB8325496D0 (en) *	1983-09-23	1983-10-26	Hider R C	Pharmaceutical compositions
GB8329043D0 (en) *	1983-10-31	1983-11-30	Hider R C	Pharmaceutical compositions
US5177068A (en) *	1984-04-19	1993-01-05	National Research Development Corporation	Pharmaceutical compositions
US5010191A (en) *	1985-08-19	1991-04-23	The Regents Of The University Of California	Imaging agents for in vivo magnetic resonance and scintigraphic imaging
MX9203808A (es) *	1987-03-05	1992-07-01	Liposome Co Inc	Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
CA1338702C (fr) *	1987-03-05	1996-11-12	Lawrence D. Mayer	Formulations d'agents liposomiques-antineoplasiques a faible teneur en medicaments-lipides
US4908371A (en) *	1987-11-10	1990-03-13	Ciba-Geigy Corporation	Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
GB8910521D0 (en) *	1989-05-08	1989-06-21	Nat Res Dev	The stabilization of organic compounds
US5443813A (en) *	1991-06-06	1995-08-22	Associated Universities, Inc.	Loading and conjugating cavity biostructures
EP0833627B1 (fr)	1995-06-10	2004-08-18	Vitra Pharmaceuticals Ltd.	Composes de fer, compositions et procedes de fabrication de ces composes et leurs utilisations
US5667933A (en) *	1996-02-26	1997-09-16	Polaroid Corporation	Image-recording element
GB9625638D0 (en) *	1996-12-10	1997-01-29	Cenes Ltd	Therapeutic antioxidants for alzheimer's diease
US8124630B2 (en)	1999-01-13	2012-02-28	Bayer Healthcare Llc	ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
CA2359244C (fr)	1999-01-13	2013-10-08	Bayer Healthcare Llc	Diphenyle urees a substitution .omega.-carboxy aryle en tant qu'inhibiteurs de la kinase p38
ATE282411T1 (de) *	2000-09-19	2004-12-15	Vitra Pharmaceuticals Ltd	Eisenverbindungen
EP2324825A1 (fr)	2002-02-11	2011-05-25	Bayer Healthcare LLC	Arylurées dotées d'une activité d'inhibition de l'angiogenèse
GB0211500D0 (en) *	2002-05-18	2002-06-26	Vitra Pharmaceuticals Ltd	Method of forming iron hydroxypyrone compounds
US7595073B2 (en) *	2003-02-28	2009-09-29	Kraft Foods Global Brands Llc	Use of siderophores and organic acids to retard lipid oxidation
UY28213A1 (es)	2003-02-28	2004-09-30	Bayer Pharmaceuticals Corp	Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
DE602004007382T2 (de) *	2003-05-20	2008-04-17	Bayer Pharmaceuticals Corp., West Haven	Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
DK1663978T3 (da)	2003-07-23	2008-04-07	Bayer Pharmaceuticals Corp	Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
CA2681545C (fr)	2007-03-28	2013-10-01	Apotex Technologies Inc.	Derives fluores de deferiprone
PL2268282T3 (pl)	2008-04-25	2015-04-30	Apotex Tech Inc	Płynny preparat deferypronu o przyjemnym smaku
ME01911B (me)	2009-07-03	2014-12-20	Apotex Tech Inc	Fluorisani derivati 3-hidroksipiridin-4-ona
BR112012023780A2 (pt)	2010-03-23	2018-07-24	Vifor (International) Ag	compostos complexos de ferro (iii) - b - cetoamida ou sais farmaceuticamente toleráveis desses, processo para a produção dos compostos complexos de ferro (iii), uso de compostos complexos de ferro (iii), fármaco contendo compostos complexos de ferro (iii) e composição contendo compostos complexos de ferro (iii)
PE20141319A1 (es) *	2011-03-29	2014-10-29	Vifor Int Ag	Compuesto de complejos de fe(iii) para el tratamiento y profilaxis de sintomas de deficiencia de hierro y anemias por deficiencia de hierro
US20140248342A1 (en)	2011-05-31	2014-09-04	Vifor (International) Ag	Fe(III) 2,4-Dioxo-1-Carbonyl Complexes For Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anaemias
RU2014144404A (ru) *	2012-04-05	2016-05-27	Вифор (Интернациональ) Аг	Железо (iii)-пиразин-комплексные соединения для лечения и профилактики явлений дефицита железа в организме и железодефицитной анемии
BR112015014917A2 (pt)	2012-12-21	2017-07-11	Vifor Int Ag	uso de compostos de complexo de ferro(iii)-2-oxo-butanodiamida ou sais farmaceuticamente aceitáveis dos mesmos; medicamento; e uso de composições

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2748142A (en) *		1956-05-29		- process of production
GB778871A (en) *	1955-02-14	1957-07-10	Sadolin & Holmblad As	Pyridinediol oxides and acetates thereof and their preparation
GB790584A (en) *	1955-02-15	1958-02-12	Sadolin & Holmblad As	Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
GB791719A (en) *	1955-02-15	1958-03-12	Sadolin & Holmblad As	Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
FR3691M (fr) *	1963-05-06	1965-11-15	Olin Mathieson	Nouvelle composition pharmaceutique utile en tant que fongicide.
NL156397B (nl) *	1968-08-31	1978-04-17	Hoechst Ag	Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.
US3968118A (en) *	1968-08-31	1976-07-06	Hoechst Aktiengesellschaft	Process for the manufacture of 1-hydroxy-2-pyridones
US3705943A (en) *	1969-07-18	1972-12-12	Olin Corp	Dialkyltin salts of substituted pyridine-1-oxides as fungicides and bactericides
EG10850A (en) *	1972-03-25	1976-06-30	Hoechst Ag	Process for the preparation of 1-hydroxy-pyridones
DE2705562A1 (de) *	1977-02-10	1978-08-17	Basf Ag	Verfahren zur herstellung von pyridonen
US4358455A (en) *	1980-12-23	1982-11-09	Merck & Co., Inc.	Aralkylamindethanol heterocyclic compounds
JPS5832812A (ja) *	1981-08-21	1983-02-25	Lion Corp	毛髪化粧料
GB2117766B (en) *	1982-03-24	1985-08-29	Nat Res Dev	Pharmaceutical compositions
GB2118176B (en) *	1982-03-24	1985-12-04	Nat Res Dev	Pharmaceutical compositions
DE3278014D1 (en) *	1982-10-01	1988-02-25	Merck & Co Inc	Aralkylaminoethanol heterocyclic compounds
GB8325496D0 (en) *	1983-09-23	1983-10-26	Hider R C	Pharmaceutical compositions
US4698431A (en) *	1985-11-12	1987-10-06	The United States Of America As Represented By The United States Department Of Energy	Hydroxypyridonate chelating agents

1983
- 1983-09-23 GB GB838325496A patent/GB8325496D0/en active Pending
1984
- 1984-09-18 US US06/651,772 patent/US4587240A/en not_active Ceased
- 1984-09-20 DE DE8484306437T patent/DE3480599D1/de not_active Expired - Lifetime
- 1984-09-20 EP EP84306437A patent/EP0138420B1/fr not_active Expired
- 1984-09-20 ZA ZA847409A patent/ZA847409B/xx unknown
- 1984-09-20 GB GB08423800A patent/GB2146990B/en not_active Expired
- 1984-09-21 DK DK453584A patent/DK161703C/da not_active IP Right Cessation
- 1984-09-21 GR GR80444A patent/GR80444B/el unknown
- 1984-09-25 JP JP59201407A patent/JPS6094966A/ja active Granted
1990
- 1990-11-19 SG SG932/90A patent/SG93290G/en unknown
1991
- 1991-01-24 HK HK70/91A patent/HK7091A/en unknown
- 1991-12-20 CY CY1574A patent/CY1574A/xx unknown
1992
- 1992-09-17 JP JP4248272A patent/JPH0811729B2/ja not_active Ceased

Also Published As

Publication number	Publication date
JPH0811729B2 (ja)	1996-02-07
JPH0566385B2 (fr)	1993-09-21
DE3480599D1 (de)	1990-01-04
DK161703B (da)	1991-08-05
EP0138420A2 (fr)	1985-04-24
HK7091A (en)	1991-02-01
SG93290G (en)	1991-01-18
GB8423800D0 (en)	1984-10-24
DK453584A (da)	1985-03-24
GB2146990B (en)	1987-05-20
GR80444B (en)	1985-01-23
JPS6094966A (ja)	1985-05-28
CY1574A (en)	1991-12-20
EP0138420B1 (fr)	1989-11-29
EP0138420A3 (en)	1987-05-20
US4587240A (en)	1986-05-06
DK453584D0 (da)	1984-09-21
GB8325496D0 (en)	1983-10-26
JPH05246992A (ja)	1993-09-24
GB2146990A (en)	1985-05-01
DK161703C (da)	1992-01-20

Publication	Publication Date	Title
GB2136807B (en)	1987-04-23	Pharmaceutical compositions
GB8423339D0 (en)	1984-10-17	Pharmaceutical compositions
GB8403668D0 (en)	1984-03-14	Pharmaceutical compositions
DE3467703D1 (en)	1988-01-07	Pharmaceutical compositions
GB8412108D0 (en)	1984-06-20	Pharmaceutical compositions
GB8423799D0 (en)	1984-10-24	Pharmaceutical compositions
GB8415975D0 (en)	1984-07-25	Pharmaceutical compositions
GB8308126D0 (en)	1983-05-05	Pharmaceutical compositions
GB8325496D0 (en)	1983-10-26	Pharmaceutical compositions
GB8329043D0 (en)	1983-11-30	Pharmaceutical compositions
GB2136806B (en)	1987-04-15	Pharmaceutical compositions
GB8317595D0 (en)	1983-08-03	Pharmaceutical compositions
CY1503A (en)	1990-08-03	Pharmaceutical compositions
GB8412569D0 (en)	1984-06-20	Pharmaceutical compositions
GB8323553D0 (en)	1983-10-05	Pharmaceutical compositions
GB8406132D0 (en)	1984-04-11	Pharmaceutical compositions
EP0136006A3 (en)	1988-07-27	Pharmaceutical compositions
GB8300767D0 (en)	1983-02-16	Pharmaceutical compositions
GB8416358D0 (en)	1984-08-01	Pharmaceutical compositions
GB8305697D0 (en)	1983-04-07	Pharmaceutical compositions
GB8425250D0 (en)	1984-11-14	Pharmaceutical compositions
GB2150435B (en)	1986-10-15	Pharmaceutical compositions
GB8317469D0 (en)	1983-08-03	Pharmaceutical compositions
GB8325628D0 (en)	1983-10-26	Pharmaceutical compositions
IE830600L (en)	1983-09-22	Pharmaceutical compositions